Tokyo Guideline 2013 (TG13) is an international guideline for the diagnosis, classification and treatment of acute cholangitis. Progress and controversy for the two years after TG13 was summarized. Endoscopic ultrasound (EUS) and magnetic resonance cholan
Tokyo guideline 2013 ((TG13)) is an international guideline for the diagnosis, classification and treatment of Acute cholangitis. Progress and controversy for the two years after TG13 was summarized. endoscopic ultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP) are both effective imaging tests for common bile duct (CBD) stones. More factors e.g. obesity may be involved in severity assessment. Initiation of broad-spectrum antibiotics addressing the typical Gram-negative enteric bacteria spectrum and early biliary drainage are the mainstay therapeutic options. Early laparoscopic exploration is also an option for stone-related nonsevere acute cholangitis besides endoscopic retrograde cholangial or p(ERC)utaneous transhepatic cholangial drainage. Surgical biliary drainage should be avoided in severe cholangitis.
閱讀全文請見：Controversy and progress for treatment of acute cholangitis after Tokyo Guidelines (TG13)
我要跟帖copyright©醫學論壇網 版權所有，未經許可不得複製、轉載或鏡像
京ICP證120392號 京公網安備110105007198 京ICP備10215607號-1 （京）網藥械信息備字（2022）第00160號
